查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1492429

溴替唑侖市場：按類型、應用和分佈 - 2024-2030 年全球預測

Brotizolam Market by Type (Capsule, Tablet), Application (Anxiety Treatment, Insomnia Treatment), Distribution - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年溴替唑侖市場規模為3.2972億美元，預計2024年將達3.500億美元，2030年將達5.1105億美元，複合年成長率為6.46%。

布替唑侖是一種苯二氮平衍生物，具有強效催眠作用，主要用於短期治療失眠。它增強大腦中神經傳導物質的活性，產生鎮靜作用，促進睡眠的啟動和維持。世界各地患有睡眠障礙，特別是失眠的人數正在增加，這增加了對布替唑侖的需求。老年人更容易出現睡眠障礙。世界老年人口的增加增加了對安眠藥（包括布替唑侖）的需求，以有效管理睡眠障礙。然而，複雜性和實現最佳品質的配方困難阻礙了該藥物的普及。潛在的副作用和難以給予適當劑量，再加上溴替唑侖的其他性能問題，阻礙了患者對該藥物的偏好。持續的研究和開發工作專注於提高安眠藥的功效和安全性，這將使溴替唑侖被納入新的、更有效的治療方法中，前景樂觀。將溴替唑侖與其他治療方法（藥物和非藥物）結合使用可提供治療失眠的綜合方法，並可能改善患者的預後。

主要市場統計
基準年[2023] 3.2972億美元
預測年份 [2024] 3.5億美元
預測年份 [2030] 51105萬美元
複合年成長率（%） 6.46%

區域洞察

美洲，特別是美國和加拿大，由於其強大的醫療基礎設施、廣泛的保險政策以及大型製藥公司的存在，為溴替唑侖市場擴張提供了巨大的機會。亞太地區的藥物開發和研究格局正在興起，這顯示了布替唑侖市場的發展潛力。研究和投資工作越來越集中於開發符合當地市場預期的藥品，包括助眠劑。布替唑侖作為亞太地區藥品製造中心的戰略地位促進了布替唑侖的成長。在歐盟，溴替唑侖市場的特點是嚴格的監管要求，重點在於消費者安全和產品功效。人口迅速老化正在增加對含有溴替唑侖的睡眠輔助劑的需求。在中東和非洲，市場動態和消費行為高度依賴特定國家的法規環境、經濟狀況以及對心理健康和藥物干預的文化態度。其中一些地區正在增加對醫療保健基礎設施和服務的投資，如果獲得監管部門的核准，這可能會為溴替唑侖等藥物開闢新的途徑。

FPNV定位矩陣

FPNV 定位矩陣對於評估溴替唑侖市場供應商的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對溴替唑侖市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對布替唑侖市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 滲出性疾病增加和人口快速老化
      • 提高對精神疾病相關症狀的認知
    • 抑制因素
      • 配方複雜且需要品管
    • 機會
      • 不斷創新研發努力，提升布替唑侖的性能與功效
      • 政府和監管機構核准布替唑侖
    • 任務
      • 與使用溴替唑侖相關的表現問題
  • 市場區隔分析
    • 類型：溴替唑侖片劑因其成本效益、穩定性和易於劑量控制而越來越受到青睞。
    • 用途：利用起效快、催眠效果顯著的溴替唑侖治療失眠
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 溴替唑侖市場：依類型

  • 膠囊
  • 藥片

第7章 溴替唑侖市場：依應用分類

  • 焦慮症治療
  • 治療失眠

第8章 溴替唑侖市場經銷商

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第9章 美洲布替唑侖市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區溴替唑侖市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲溴替唑侖市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • SUSMED 創新失眠治療應用程式獲得核准
    • 擴大 QUVIVIQ® 的使用範圍：策略性納入 CVS 保險範圍將促進失眠治療的普及
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-6B0EA079758A

[183 Pages Report] The Brotizolam Market size was estimated at USD 329.72 million in 2023 and expected to reach USD 350.00 million in 2024, at a CAGR 6.46% to reach USD 511.05 million by 2030.

Brotizolam is a benzodiazepine derivative with potent hypnotic properties, making it primarily used in the short-term management of insomnia. It functions by enhancing the action of neurotransmitters in the brain to produce a calming effect, thereby facilitating the onset and maintenance of sleep. The increasing number of individuals suffering from sleep disorders, particularly insomnia, across the globe has accentuated the need for brotizolam. Older adults are more prone to sleep disturbances. The global increase in the elderly population has led to a higher need for hypnotic medications, including brotizolam, to manage sleep disorders effectively. However, complexities in achieving optimum quality and formulation difficulties can hamper the widespread adoption of the medicine. Potential side effects and difficulties in delivering the right dosage, coupled with other performance issues of brotizolam, hinder patient preference for the drug. Continuous research and development activities focusing on improving the efficacy and safety profile of hypnotic drugs provide a positive outlook for brotizolam, incorporating it into newer, more effective treatment regimens. There's an opportunity to explore and develop combination therapies where brotizolam is used alongside other treatments, both pharmacological and non-pharmacological, to provide a comprehensive approach to managing insomnia with potentially enhanced patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 329.72 million
Estimated Year [2024] USD 350.00 million
Forecast Year [2030] USD 511.05 million
CAGR (%) 6.46%

Regional Insights

In the Americas region, particularly in the U.S. and Canada, there is considerable opportunity for expanding the brotizolam market, driven by the presence of a robust healthcare infrastructure, expansive insurance policies, and key pharmaceutical companies. APAC's drug development and research landscape is emerging, signifying the potential for progress in the brotizolam market. Research and investment efforts are progressively emphasizing the development of pharmaceuticals, including sleeping aids, that harmonize with local market expectations. APAC's strategic position as a pharmaceutical manufacturing hub has enabled the growth of brotizolam medication. In the EU, the market for brotizolam is characterized by stringent regulatory requirements focusing on consumer safety and product efficacy. The presence of a rapidly aging population accentuates the need for sleeping aids, including brotizolam. In the Middle East and Africa, the market dynamics and consumer behavior vastly depend on the specific country's regulatory environment, economic conditions, and cultural attitudes toward mental health and pharmaceutical interventions. Some regions within these areas are seeing increased investments in healthcare infrastructure and services, potentially opening up new avenues for medications such as brotizolam, subject to regulatory approvals.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Brotizolam Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of seeping disorders and a rapidly aging population
      • Growing awareness about symptoms related to mental health disorders
    • Market Restraints
      • Formulation complexities and need for high quality control
    • Market Opportunities
      • Ongoing innovations and R&D initiatives to improve the performance and efficacy of brotizolam
      • Supportive government and regulatory approvals for brotizolam
    • Market Challenges
      • Performance issues associated with the use of brotizolam
  • Market Segmentation Analysis
    • Type: Emerging preference for tablets of brotizolam owing to their cost-effectiveness, stability, and ease of controlling dosage
    • Application: Insomnia treatment benefiting from the rapid onset and pronounced hypnotic effect of brotizolam
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Brotizolam Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Brotizolam Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

SUSMED, Inc. Secures Approval for Innovative Insomnia Treatment App

SUSMED, Inc. has received approval from the Ministry of Health, Labour and Welfare (MHLW) for its SUSMED Med CBT-i App, an insomnia treatment application. The smartphone-based app is designed to offer cognitive behavioral therapy for insomnia (CBT-I) over a course of nine weeks, showing significant therapeutic benefits for individuals suffering from insomnia. By adhering to the app's guidance, users can see an improvement in their symptoms, while physicians can track their progress through an integrated management system. This approval marks a pivotal step towards the application's market launch, with SUSMED currently working towards securing insurance coverage for the product. [Published On: 2023-08-25]

Expanding Access to QUVIVIQ(R): Strategic Inclusion in CVS Coverage Enhances Insomnia Therapy Reach

Idorsia Ltd and its U.S. subsidiary have announced a significant development, that CVS would include QUVIVIQ (daridorexant) CIV in its Performance Drug List (PDL), effective immediately. This inclusion marks a pivotal moment, as it significantly broadens access to QUVIVIQ, a modern prescription insomnia treatment, by encompassing an audience of around 20 million people enrolled under CVS's plan. With this move, QUVIVIQ secures coverage by two of the United States' major insurance providers, Express Scripts and CVS, in addition to various regional plans and TRICARE, the dedicated healthcare program for U.S. military members, veterans, and their families. [Published On: 2023-07-10]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Brotizolam Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Brotizolam Market, highlighting leading vendors and their innovative profiles. These include Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, Boehringer Ingelheim International GmbH., Choseido Pharmaceutical Co., Ltd., Daiko Pharmaceutical Co.,Ltd., Delphis Pharmaceutical, Kyowa Pharmaceutical Industry Co.,Ltd., Medilux Laboratories Pvt. Ltd., Merck KGaA, Mylan N.V., Nichi-Iko Pharmaceutical Co.,Ltd., Nipro Corp., Nissin Pharmaceutical Co.,Ltd., Ohara Pharmaceutical Co.,Ltd., Sannova Analytical LLC, Tatsumi Kagaku Co.,Ltd., Teva Takeda Pharma Ltd., and Yoshindo Inc..

Market Segmentation & Coverage

This research report categorizes the Brotizolam Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Capsule
    • Tablet
  • Application
    • Anxiety Treatment
    • Insomnia Treatment
  • Distribution
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of seeping disorders and a rapidly aging population
      • 5.1.1.2. Growing awareness about symptoms related to mental health disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Formulation complexities and need for high quality control
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovations and R&D initiatives to improve the performance and efficacy of brotizolam
      • 5.1.3.2. Supportive government and regulatory approvals for brotizolam
    • 5.1.4. Challenges
      • 5.1.4.1. Performance issues associated with the use of brotizolam
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Emerging preference for tablets of brotizolam owing to their cost-effectiveness, stability, and ease of controlling dosage
    • 5.2.2. Application: Insomnia treatment benefiting from the rapid onset and pronounced hypnotic effect of brotizolam
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Brotizolam Market, by Type

  • 6.1. Introduction
  • 6.2. Capsule
  • 6.3. Tablet

7. Brotizolam Market, by Application

  • 7.1. Introduction
  • 7.2. Anxiety Treatment
  • 7.3. Insomnia Treatment

8. Brotizolam Market, by Distribution

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Brotizolam Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Brotizolam Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Brotizolam Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. SUSMED, Inc. Secures Approval for Innovative Insomnia Treatment App
    • 12.3.2. Expanding Access to QUVIVIQ(R): Strategic Inclusion in CVS Coverage Enhances Insomnia Therapy Reach
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. BROTIZOLAM MARKET RESEARCH PROCESS
  • FIGURE 2. BROTIZOLAM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BROTIZOLAM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BROTIZOLAM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL BROTIZOLAM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BROTIZOLAM MARKET DYNAMICS
  • FIGURE 7. GLOBAL BROTIZOLAM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL BROTIZOLAM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BROTIZOLAM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BROTIZOLAM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BROTIZOLAM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. BROTIZOLAM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BROTIZOLAM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BROTIZOLAM MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL BROTIZOLAM MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL BROTIZOLAM MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL BROTIZOLAM MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL BROTIZOLAM MARKET SIZE, BY CAPSULE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL BROTIZOLAM MARKET SIZE, BY CAPSULE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL BROTIZOLAM MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL BROTIZOLAM MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL BROTIZOLAM MARKET SIZE, BY ANXIETY TREATMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL BROTIZOLAM MARKET SIZE, BY ANXIETY TREATMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL BROTIZOLAM MARKET SIZE, BY INSOMNIA TREATMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL BROTIZOLAM MARKET SIZE, BY INSOMNIA TREATMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL BROTIZOLAM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL BROTIZOLAM MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL BROTIZOLAM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL BROTIZOLAM MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL BROTIZOLAM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL BROTIZOLAM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS BROTIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS BROTIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES BROTIZOLAM MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES BROTIZOLAM MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC BROTIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BROTIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM BROTIZOLAM MARKET SIZE, BY DISTRIBUTION, 2024-2030 (USD MILLION)
  • TABLE 281. BROTIZOLAM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. BROTIZOLAM MARKET, FPNV POSITIONING MATRIX, 2023